Total Payments
$14,016
2024 Payments
$2,028
Companies
44
Transactions
613
Medicare Patients
2,674
Medicare Billing
$302,339
Payment Breakdown by Category
Food & Beverage$13,835 (98.7%)
Education$180.08 (1.3%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $13,835 | 594 | 98.7% |
| Education | $180.08 | 19 | 1.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $2,207 | 106 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $1,590 | 36 | $0 (2021) |
| Lilly USA, LLC | $1,537 | 66 | $0 (2024) |
| ABBVIE INC. | $1,520 | 77 | $0 (2024) |
| PFIZER INC. | $1,037 | 33 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $1,022 | 43 | $0 (2024) |
| Amgen Inc. | $962.11 | 49 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $554.52 | 32 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $392.13 | 20 | $0 (2024) |
| Janssen Biotech, Inc. | $387.05 | 20 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,028 | 93 | Boehringer Ingelheim Pharmaceuticals, Inc. ($350.44) |
| 2023 | $2,188 | 112 | Lilly USA, LLC ($361.65) |
| 2022 | $1,595 | 83 | ABBVIE INC. ($272.03) |
| 2021 | $2,243 | 98 | AbbVie Inc. ($597.31) |
| 2020 | $965.58 | 44 | Janssen Pharmaceuticals, Inc ($337.29) |
| 2019 | $1,441 | 52 | Janssen Pharmaceuticals, Inc ($671.99) |
| 2018 | $1,726 | 61 | Novo Nordisk Inc ($620.14) |
| 2017 | $1,829 | 70 | Novo Nordisk Inc ($481.22) |
All Payment Transactions
613 individual payment records from CMS Open Payments — Page 1 of 25
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $15.22 | General |
| Category: Inflammation | ||||||
| 12/16/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $34.63 | General |
| Category: IMMUNOLOGY | ||||||
| 12/10/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $17.63 | General |
| Category: Obesity | ||||||
| 12/09/2024 | Amgen Inc. | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $17.76 | General |
| Category: Inflammation/Rare Disease | ||||||
| 12/06/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $25.55 | General |
| Category: VACCINES | ||||||
| 12/02/2024 | PFIZER INC. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $28.86 | General |
| Category: PAIN | ||||||
| 11/25/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $21.65 | General |
| Category: IMMUNOLOGY | ||||||
| 11/21/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $10.10 | General |
| Category: NEUROSCIENCE | ||||||
| 11/19/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $22.58 | General |
| Category: Diabetes | ||||||
| 11/18/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $19.29 | General |
| Category: Immunology | ||||||
| 11/11/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $31.52 | General |
| 11/05/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $18.19 | General |
| Category: Inflammation | ||||||
| 11/04/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $32.56 | General |
| Category: IMMUNOLOGY | ||||||
| 10/29/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $16.85 | General |
| Category: Obesity | ||||||
| 10/21/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $21.83 | General |
| Category: Cardiology | ||||||
| 10/16/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $20.47 | General |
| Category: Immunology | ||||||
| 10/14/2024 | Sandoz Inc. | HYRIMOZ (Biological) | Food and Beverage | In-kind items and services | $16.27 | General |
| Category: Immunology | ||||||
| 10/10/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $33.70 | General |
| Category: DIABETES | ||||||
| 10/08/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $13.38 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/04/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $22.44 | General |
| Category: PAIN | ||||||
| 10/01/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $23.11 | General |
| Category: Diabetes | ||||||
| 09/30/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $27.99 | General |
| Category: IMMUNOLOGY | ||||||
| 09/24/2024 | SOBI, INC | KINERET (Drug) | Food and Beverage | In-kind items and services | $28.15 | General |
| Category: IMMUNOLOGY | ||||||
| 09/17/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $28.58 | General |
| Category: Diabetes | ||||||
| 09/16/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $22.54 | General |
| Category: Inflammation | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 14 | 640 | 1,141 | $206,995 | $69,553 |
| 2022 | 12 | 721 | 1,281 | $234,979 | $74,186 |
| 2021 | 13 | 811 | 1,499 | $300,820 | $98,646 |
| 2020 | 13 | 502 | 839 | $182,681 | $59,954 |
Total Patients
2,674
Total Services
4,760
Medicare Billing
$302,339
Procedure Codes
52
All Medicare Procedures & Services
52 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 121 | 347 | $95,772 | $29,878 | 31.2% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 88 | 97 | $36,472 | $11,121 | 30.5% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 27 | 95 | $18,620 | $6,056 | 32.5% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 26 | 53 | $14,840 | $5,268 | 35.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 46 | 72 | $13,248 | $4,467 | 33.7% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 17 | 18 | $9,810 | $2,607 | 26.6% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2023 | 33 | 33 | $2,574 | $2,502 | 97.2% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 127 | 252 | $2,016 | $1,921 | 95.3% |
| 90732 | Pneumococcal vaccine, 23-valent | Office | 2023 | 12 | 12 | $2,172 | $1,570 | 72.3% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 37 | 38 | $2,280 | $1,228 | 53.9% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2023 | 14 | 24 | $1,560 | $917.28 | 58.8% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2023 | 12 | 13 | $2,561 | $874.90 | 34.2% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 68 | 75 | $4,350 | $754.54 | 17.3% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 12 | 12 | $720.00 | $387.84 | 53.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 139 | 350 | $96,700 | $28,478 | 29.5% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 100 | 108 | $40,608 | $13,675 | 33.7% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 31 | 133 | $26,068 | $7,563 | 29.0% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 37 | 85 | $23,800 | $7,021 | 29.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 54 | 80 | $14,720 | $4,678 | 31.8% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 20 | 22 | $11,990 | $3,540 | 29.5% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 38 | 40 | $3,200 | $2,725 | 85.2% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2022 | 33 | 59 | $3,835 | $2,312 | 60.3% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 43 | 45 | $2,700 | $1,400 | 51.9% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2022 | 22 | 24 | $4,728 | $1,250 | 26.4% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 71 | 79 | $4,582 | $796.81 | 17.4% |
About Dr. Peter Eupierre, M.D
Dr. Peter Eupierre, M.D is a Internal Medicine healthcare provider based in Melrose Park, Illinois. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/02/2005. The National Provider Identifier (NPI) number assigned to this provider is 1528069481.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Peter Eupierre, M.D has received a total of $14,016 in payments from pharmaceutical and medical device companies, with $2,028 received in 2024. These payments were reported across 613 transactions from 44 companies. The most common payment nature is "Food and Beverage" ($13,835).
As a Medicare-enrolled provider, Eupierre has provided services to 2,674 Medicare beneficiaries, totaling 4,760 services with total Medicare billing of $302,339. Data is available for 4 years (2020–2023), covering 52 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Location Melrose Park, IL
- Active Since 08/02/2005
- Last Updated 12/06/2007
- Taxonomy Code 207R00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1528069481
Products in Payments
- XARELTO (Drug) $1,007
- TRULICITY (Drug) $950.45
- ELIQUIS (Drug) $909.14
- Ozempic (Drug) $696.95
- INVOKANA (Drug) $576.37
- Victoza (Drug) $541.18
- JARDIANCE (Drug) $497.82
- RINVOQ (Biological) $458.06
- UBRELVY (Drug) $437.40
- ENTRESTO (Drug) $389.71
- Rybelsus (Drug) $333.63
- KRYSTEXXA (Biological) $325.56
- TREMFYA (Drug) $313.22
- QULIPTA (Drug) $299.59
- MOUNJARO (Drug) $288.57
- NURTEC ODT (Drug) $249.29
- Prolia (Biological) $232.86
- SKYRIZI (Biological) $227.98
- SOLIQUA (Drug) $220.76
- Xultophy 100/3.6 (Drug) $216.45
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Melrose Park
Michael Cooperman, Md, MD
Internal Medicine — Payments: $168,260
Internal Medicine $168,260
Rodney Schainis, M.d, M.D
Internal Medicine — Payments: $9,103
Internal Medicine $9,103
Dr. Michelle Forson, M.d, M.D
Internal Medicine — Payments: $7,189
Internal Medicine $7,189
Dr. James Koop, M.d, M.D
Internal Medicine — Payments: $6,653
Internal Medicine $6,653
Mrs. Helene Ruiz Pla, Md, MD
Internal Medicine — Payments: $4,272
Internal Medicine $4,272
Dr. Harvey Azarva, Md, MD
Internal Medicine — Payments: $2,744
Internal Medicine $2,744